Literature DB >> 7378264

Increased plasma propranolol binding in myocardial infarction.

P A Routledge, W W Stargel, G S Wagner, D G Shand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7378264      PMCID： PMC1429969          DOI： 10.1111/j.1365-2125.1980.tb01077.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  13 in total

1.  Plasma binding and the affinity of propranolol for a beta receptor in man.

Authors:  D G McDevitt; M Frisk-Holmberg; J W Hollifield; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1976-08       Impact factor: 6.875

2.  A controlled trial of propranolol in acute myocardial infarction.

Authors:  R Balcon; D E Jewitt; J P Davies; S Oram
Journal:  Lancet       Date:  1966-10-29       Impact factor: 79.321

3.  Absence of prophylactic effect of propranolol in myocardial infarction.

Authors:  J Clausen; M Felsby; F S Jorgensen; B L Nielsen; J Roin; B Strange
Journal:  Lancet       Date:  1966-10-29       Impact factor: 79.321

4.  Trial of propranolol in acute myocardial infarction.

Authors:  R M Norris; D E Caughey; P J Scott
Journal:  Br Med J       Date:  1968-05-18

5.  Sequential changes of plasma proteins after myocardial infarction.

Authors:  B G Johansson; C O Kindmark; E Y Trell; F A Wollheim
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

6.  [Differentiated quantitative serum protein determination during myocardial infarct].

Authors:  G W Bachmann; M E Weiss; W Rapp
Journal:  Schweiz Med Wochenschr       Date:  1968-11-16

7.  Reduction of enzyme levels by propranolol after acute myocardial infarction.

Authors:  T Peter; R M Norris; E D Clarke; M K Heng; B N Singh; B Williams; D R Howell; P K Ambler
Journal:  Circulation       Date:  1978-06       Impact factor: 29.690

8.  Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.

Authors:  D J Coltart; D G Shand
Journal:  Br Med J       Date:  1970-09-26

9.  Protective effect of propranolol in threatened myocardial infarction.

Authors:  R M Norris; E D Clarke; N L Sammel; W M Smith; B Williams
Journal:  Lancet       Date:  1978-10-28       Impact factor: 79.321

10.  Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein.

Authors:  K M Piafsky; O Borgá; I Odar-Cederlöf; C Johansson; F Sjöqvist
Journal:  N Engl J Med       Date:  1978-12-28       Impact factor: 91.245
View more
  6 in total

Review 1.  Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

Authors:  R Zini; P Riant; J Barré; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

2.  The plasma protein binding of basic drugs.

Authors:  P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

3.  beta-blocker plasma concentrations and inflammatory disease: clinical implications.

Authors:  R E Schneider; H Bishop
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

Review 4.  Therapeutic drug monitoring of antiarrhythmic agents.

Authors:  J E Brown; D G Shand
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

Review 5.  Free drug concentration monitoring in clinical practice. Rationale and current status.

Authors:  C K Svensson; M N Woodruff; J G Baxter; D Lalka
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

6.  Alpha 1-acid glycoprotein concentrations and propranolol binding in elderly patients with acute illness.

Authors:  J W Paxton; R H Briant
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.